US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jade Biosciences

7.81

-0.4200-5.10%

Volume:28.53K

Turnover:226.23K

Market Cap:254.81M

PE:-0.42

High:8.21

Open:8.21

Low:7.70

Close:8.23

52wk High:105.00

52wk Low:6.57

Shares:32.63M

Float Shares:16.33M

Volume Ratio:0.48

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-18.7916

EPS(LYR):-9.3958

ROE:--

ROA:--

PB:0.09

PE(LYR):-0.83

Loading ...

Overview Company News Filings

Jade Biosciences Inc. Completes Merger with Aerovate Therapeutics, Inc. to Advance Autoimmune Disease Therapies

US Equity Futures Higher as Trump Considers 80% China Tariffs

MT Newswires Live

Jade Biosciences Initiated at Outperform by Wedbush

Stifel Nicolaus Initiates Coverage on Jade Biosciences With Buy Rating, $19 Price Target

MT Newswires Live

Aerovate Therapeutics Completes Merger with Jade Biosciences

Aerovate Therapeutics Inc trading halted, news pending

Press Release: Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million

BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/JBIO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":7.81,"timestamp":1756137934037,"preClose":8.23,"halted":0,"volume":28529,"delay":0,"floatShares":16329500,"shares":32626730,"eps":-18.7916,"marketStatus":"Trading","change":-0.42,"latestTime":"08-25 12:08:07 EDT","open":8.21,"high":8.21,"low":7.7,"amount":226234.741768,"amplitude":0.061968,"askPrice":7.92,"askSize":27,"bidPrice":7.71,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-18.7916,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":2,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":8.23,"postHourTrading":{"tag":"盘后","latestPrice":8.23,"preClose":8.23,"latestTime":"17:53 EDT","volume":4746,"amount":39054.86,"timestamp":1755899630024},"volumeRatio":0.476502,"impliedVol":0.816,"impliedVolPercentile":0.5522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":16329500,"roa":"--","roe":"--","lyrEps":-9.3958,"volumeRatio":0.476502,"shares":32626730,"dividePrice":0,"high":8.21,"amplitude":0.061968,"preClose":8.23,"low":7.7,"week52Low":6.565,"pbRate":"0.09","week52High":105,"institutionHeld":0,"latestPrice":7.81,"committee":-0.741935,"eps":-18.7916,"divideRate":0,"volume":28529,"delay":0,"ttmEps":-18.7916,"open":8.21,"prevYearClose":92.75,"prevWeekClose":8.23,"prevMonthClose":7.19,"prevQuarterClose":9.99,"fiveDayClose":7.5,"twentyDayClose":7.75,"sixtyDayClose":7.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86},{"date":"2025-04-29","symbol":"JBIO","amount":2.4,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-25","defaultRemindTime":1745933400000,"name":"Jade Biosciences","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-28","payableDate":"2025-04-25","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-04-28"},{"market":"US","date":"2025-04-29","symbol":"JBIO","defaultRemindTime":1745933400000,"type":"split","dateTimestamp":1745899200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-04-25","symbol":"JBIO","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745553600000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2025-03-27","symbol":"JBIO","fiscalQuarterEnding":"2024/12","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.2,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1752552000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2025-08-22","current":-2.56269,"percent":0.535211,"low":-3.822008,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"high":-2.319279,"avg":-2.814374,"sd":0.435503,"marketCap":240785267},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267}],"updateTime":1756138087354},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535600725","title":"Jade Biosciences Inc. Completes Merger with Aerovate Therapeutics, Inc. to Advance Autoimmune Disease Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2535600725","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535600725?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:20","pubTimestamp":1747254048,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. has announced the completion of its merger with Aerovate, resulting in the formation of a new entity named the Combined Company. This merger involved the integration of Jade Biosciences, LLC into Jade Biosciences, Inc., and the newly formed entity will continue under the name Jade Biosciences, Inc. Led by Jade's pre-merger management team, the Combined Company will focus on developing innovative biologic therapies for autoimmune diseases. The merger reflects Jade Biosciences' strategy to enhance its development capabilities and expand its portfolio in the biotech industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jade Biosciences Inc. published the original content used to generate this news brief via EDGAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL5gSsBv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"2534866054","title":"US Equity Futures Higher as Trump Considers 80% China Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2534866054","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534866054?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:14","pubTimestamp":1746792858,"startTime":"0","endTime":"0","summary":"US stock futures were higher in premarket activity Friday after US President Donald Trump posted on Truth Social that an \"80% tariff on China seems right!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"96c6cdb6c2a806f901a7b6e5d83c6d19","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","DJX","TSYW.SI","IOVA","BK4588","PSQ","USJW.SI","MYMmain","BK4215","QID","ZKIN","USAW.SI","MNQmain","QLD","DOG","SDOW","BK4539","BK4568","TQQQ","JBIO","NQmain","BK4006","BK4585","UDOW","CRVS","VEEE","NVIW.SI",".SPX","EQR","DDM","DXD",".IXIC",".DJI","BBGI","BK4125","SQQQ","BK4190"],"gpt_icon":1},{"id":"2533953012","title":"Jade Biosciences Initiated at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2533953012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533953012?lang=en_us&edition=fundamental","pubTime":"2025-05-07 23:57","pubTimestamp":1746633420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 07, 2025 11:57 ET (15:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"gpt_icon":0},{"id":"2533837005","title":"Stifel Nicolaus Initiates Coverage on Jade Biosciences With Buy Rating, $19 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2533837005","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533837005?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:38","pubTimestamp":1746445130,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. (JBIO) has an average rating of overweight and mean price target of $62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO","SF"],"gpt_icon":0},{"id":"2532835187","title":"Aerovate Therapeutics Completes Merger with Jade Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2532835187","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532835187?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:52","pubTimestamp":1746132723,"startTime":"0","endTime":"0","summary":"Aerovate Therapeutics ( ($AVTE) ) has provided an update. On April 28, 2025, Jade Biosciences, Inc. completed its merger with Aerovate Therapeutics...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aerovate-therapeutics-completes-merger-with-jade-biosciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aerovate-therapeutics-completes-merger-with-jade-biosciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2531291572","title":"Aerovate Therapeutics Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2531291572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531291572?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:50","pubTimestamp":1745884207,"startTime":"0","endTime":"0","summary":"19:50 EDT Aerovate Therapeutics (AVTE) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-movin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aerovate-therapeutics-inc-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aerovate-therapeutics-inc-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","LENZ","BK4007","BK4539","BK4139","AVTE"],"gpt_icon":0},{"id":"2530840242","title":"Press Release: Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2530840242","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530840242?lang=en_us&edition=fundamental","pubTime":"2025-04-28 22:19","pubTimestamp":1745849940,"startTime":"0","endTime":"0","summary":"Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million. Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases. Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026. The combined company will operate as \"Jade Biosciences, Inc.\" and will trade on Nasdaq under the ticker symbol \"JBIO\". SAN FRANCISCO and VANCOUVER, British Columbia, April 28, 2025  -- Jade Biosciences, Inc. , a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the completion of its previously announced merger with Aerovate Therapeutics, Inc. . The combined company will operate as Jade Biosciences, Inc., with its shares expected to begin trading on the Nasdaq Capital Market on April 29, 2025, under the ticker symbol \"JBIO.\". Follow","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","BK4539","AVTE","LENZ","JBIO"],"gpt_icon":0},{"id":"2529081358","title":"BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2529081358","media":"Reuters","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529081358?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:02","pubTimestamp":1745236937,"startTime":"0","endTime":"0","summary":"BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related ProposalsApril 21 (Reuters) - Aerovate Therapeutics Inc AVTE.O:AEROVATE THERAPEUTICS STOCKHOLDERS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8QNVVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","AVTE","BK4139"],"gpt_icon":0},{"id":"2529803704","title":"Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803704","media":"PR Newswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803704?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236800,"startTime":"0","endTime":"0","summary":"—Aerovate Board of Directors approves 1-for-35 reverse stock split—。WALTHAM, Mass., April 21, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc.   today announced that its stockholders have approved the proposed merger  with Jade Biosciences, Inc. , along with all proposals related to the Merger. The proposals were voted upon at Aerovate's special meeting of stockholders held on April 16, 2025 , including a reverse stock split of Aerovate's common stock to be effected at the discretion of the Board of Directors  within the parameters approved by Aerovate's stockholders.The previously announced special cash dividend  will not be affected by the reverse stock split. An aggregate Cash Dividend of $69.6 million, or an estimated $2.40 per share, will be payable in cash to Aerovate's stockholders of record as of April 25, 2025 based on their holdings as of that date prior to the reverse stock split. The estimated per share dividend is based on 28,985,019 shares of Aerovate's common stock outst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aerovate-therapeutics-stockholders-approve-proposed-120000718.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aerovate-therapeutics-stockholders-approve-proposed-120000718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","JBIO","BK4539","AVTE","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":29,"code":"91000000","status":"200"}]}}